#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loss of consciousness Glycogen storage disease type II Optic glioma Anaplastic thyroid cancer Osteosarcoma recurrent Squamous cell carcinoma of the oral cavity Rhabdoid tumour Lymphangioma Myxoid liposarcoma Deafness neurosensory Piriformis syndrome Hepatitis B Laryngeal squamous cell carcinoma Albright's disease Chondrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Life with Disease Marginal zone lymphoma – Basic Information Osteosarcoma metastatic – Basic Information Pulmonary sarcoidosis – Life with Disease Medulloblastoma recurrent – Diagnostics Niemann-Pick disease – Life with Disease Progressive supranuclear palsy – Basic Information Idiopathic pulmonary fibrosis – Trials in Disease Mucous membrane pemphigoid – Basic Information IgA nephropathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ARI0008 Calcium Prednisolone Sodium Succinate Darovasertib Dexchlorpheniramine Maleate Vibozilimod PHENTOLAMINE MESILATE Rct2100 Voriconazole Olmesartan Medoxomil Hydroxyzine Hydrochloride Peppermint Oil Degarelix Acetate Deutivacaftor Betula Pendula Pollen Extract MB-CART2219.1 Rapcabtagene Autoleucel Quercus Ilex Allergen Extract Tisotumab Vedotin Progesterone Ph. Eur. More therapies…

    Learn about Your Condition

    Muscle hypertrophy Endometriosis Thrombosis Femoral neck fracture Arteriovenous malformation Tinnitus Cataract Primary hyperthyroidism Enteritis Pancreaticoduodenectomy Axial spondyloarthritis Bladder cancer stage II Cough Glioma Oral neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST CLDN6 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A CATHEPSIN HYDROLYSABLE DIPEPTIDE VC LINKER
    • Glatiramer Acetate
    Austria Belgium Czechia France Germany Ireland +2

  • Safety and effectiveness study of PN6047 HCl in adults with peripheral neuropathic pain and mechanical allodynia

    Not yet recruiting

    2 1
    Spain

  • Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Methotrexate
    • Vincristine
    • Carboplatin
    Belgium Denmark France Germany The Netherlands

  • Study of cardiac atrial stem cells injected into heart muscle for treating advanced heart failure in patients with prior heart attack and reduced heart function

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Chronic left ventricular failure
    • Left ventricular failure
    Belgium

  • Study of Empagliflozin to Improve Heart Function in Adults with Pulmonary Arterial Hypertension

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Empagliflozin
    Germany

  • Study of bosentan, prednisone and prednisolone in patients with newly diagnosed or relapsing giant cell arteritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • Bosentan
    • Prednisolone
    • Prednisone
    France
Previous Page
1 … 778 779 780 781 782 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!